Since TGF-β participates in the pathogenesis of glioma via supporting tumor growth and self-renewal of initiating stem cells [45], inhibiting the TGF-β/Smad4 pathway may contribute to the antitumor effects of ASP in glioma. This evidence concerns the gene SMAD4 and glioma.